Skip to main content

Advertisement

SpringerLink
Log in

Apoptosis participates to liver damage in HSV-induced fulminant hepatitis

  • Published:
Apoptosis Aims and scope Submit manuscript

Abstract

Background: HSV fulminant hepatitis is a rare pathology. Rapid hepatic failure, as a consequence of extended liver damage, has generally been attributed to necrosis. As apoptosis can constitute another way for hepatocytes to die, we decided to investigate whether programmed cell death took place during HSV fulminant hepatitis. Methods: Liver sections were obtained from two cases of fulminant herpetic hepatitis as well as from hepatitis B virus and Rickettsia-infected livers. Herpes simplex virus infection was confirmed using in situ hybridization. Apoptosis was assessed by histopathological examination, p53, activated-caspase 3 and Fas immunohistochemistry and TUNEL labeling. Results: We report that the number of cells expressing activated-caspase 3 was largely increased in fulminant herpes simplex virus hepatitis, when compared to livers chronically infected by hepatitis B virus or from a Rickettsial acute hepatitis. Apoptosis of hepatocytes was confirmed by a positive double-staining for activated-caspase 3 and hepatocytes. Finally, the apoptotic process has progressed beyond the step of nuclear DNA cleavage as demonstrated by TUNEL labeling. Conclusion: These data as a whole show that apoptosis is responsible, at least partially, for liver damage during HSV fulminant hepatitis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Anuras S, Summers R. Fulminant herpes simplex hepatitis in an adult: Report of a case in renal transplant recipient. Gastroenterology 1976; 70: 425–428.

    Google Scholar 

  2. Chase RA, Pottage JC, Jr, Haber MH, Kistler G, Jensen D, Levin S. Herpes simplex viral hepatitis in adults: Two case reports and review of the literature. Rev Infect Dis 1987; 9: 329–333.

    Google Scholar 

  3. Farr RW, Short S, Weissman D. Fulminant hepatitis during herpes simplex virus infection in apparently immunocompetent adults: Report of two cases and review of the literature. Clin Infect Dis 1997; 24: 1191–1194.

    Google Scholar 

  4. Goyette RE, Donowho EM, Jr, Hieger LR, Plunkett GD. Fulminant herpesvirus hominis hepatitis during pregnancy.Obstet Gynecol 1974; 43: 191–195.

    Google Scholar 

  5. Jacques SM, Qureshi F. Herpes simplex virus hepatitis in pregnancy: A clinicopathologic study of three cases. Hum Pathol 1992; 23: 183–187.

    Google Scholar 

  6. Tomita T, Garcia F, Mowry M. Herpes simplex hepatitis before and after acyclovir treatment. Immunohistochemical and in situ hybridization study. Arch Pathol Lab Med 1992; 116: 173–177.

    Google Scholar 

  7. Salomon RN, Diaz-Cano S. Introduction to apoptosis. Diagn Mol Pathol 1995; 4: 235–238.

    Google Scholar 

  8. Hofman P, Auberger P. Roles and mechanisms of apoptosis in infectious diseases. Ann Pathol 2000; 20: 313–322.

    Google Scholar 

  9. Shen Y, Shenk TE. Viruses and apoptosis. Curr Opin Genet Dev 1995; 5: 105–111.

    Google Scholar 

  10. Reed JC. Mechanisms of apoptosis [In Process Citation]. Am J Pathol 2000; 157: 1415–1430.

    Google Scholar 

  11. Galle PR, Hofmann WJ, Walczak H, et al. Involvement of the CD95 (APO-1/Fas) receptor and ligand in liver damage. J Exp Med 1995; 182: 1223–1230.

    Google Scholar 

  12. Nagata S, Golstein P. The Fas death factor. Science 1995; 267: 1449–1456.

    Google Scholar 

  13. Zhang H, Cook J, Nickel J, et al. Reduction of liver Fas expression by an antisense oligonucleotide protects mice from fulminant hepatitis. Nat Biotechnol 2000; 18: 862–867.

    Google Scholar 

  14. Slee EA, Adrain C, Martin SJ. Executioner caspases-3,-6 and-7 perform distinct, non-redundant, roles during the demolition phase of apoptosis. J Biol Chem 2000; 276: 7320–7326.

    Google Scholar 

  15. Faleiro L, Lazebnik Y. Caspases disrupt the nuclear-cytoplasmic barrier. J Cell Biol 2000; 151: 951–959.

    Google Scholar 

  16. Leopardi R, Roizman B. The herpes simplex virus major regulatory protein ICP4 blocks apoptosis induced by the virus or by hyperthermia. Proc Natl Acad Sci USA 1996; 93: 9583–9587.

    Google Scholar 

  17. Leopardi R, Van Sant C, Roizman B. The herpes simplex virus 1 protein kinase US3 is required for protection from apoptosis induced by the virus. Proc Natl Acad Sci USA 1997; 94: 7891–7896.

    Google Scholar 

  18. Koyama AH, Miwa Y. Suppression of apoptotic DNA fragmentation in herpes simplex virus type 1-infected cells. J Virol 1997; 71: 2567–2571.

    Google Scholar 

  19. Galvan V, Roizman B. Herpes simplex virus 1 induces and blocks apoptosis at multiple steps during infection and protects cells from exogenous inducers in a cell-type-dependent manner. Proc Natl Acad Sci USA 1998; 95: 3931–3936.

    Google Scholar 

  20. Jerome KR, Tait JF, Koelle DM, Corey L. Herpes simplex virus type 1 renders infected cells resistant to cytotoxic T-lymphocyte-induced apoptosis. J Virol 1998; 72: 436–441.

    Google Scholar 

  21. Galvan V, Brandimarti R, Roizman B. Herpes simplex virus 1 blocks caspase-3-independent and caspase-dependent pathways to cell death. J Virol 1999; 73: 3219–3226.

    Google Scholar 

  22. Zachos G, Koffa M, Preston CM, Clements JB, Conner J. Herpes simplex virus type 1 blocks the apoptotic host cell defense mechanisms that target Bcl-2 and manipulates activation of p38 mitogen-activated protein kinase to improve viral replication. J Virol 2001; 75: 2710–2728.

    Google Scholar 

  23. Koyama AH, Adachi A. Induction of apoptosis by herpes simplex virus type 1. J Gen Virol 1997; 78: 2909–2912.

    Google Scholar 

  24. Bernard B, Fest T, Prétet JL, Mougin C. Staurosporine-induced apoptosis of HPV positive and negative human cervical cancer cells from different points in the cell cycle. Cell Death Differ 2001; 8: 234–244.

    Google Scholar 

  25. Bernard C, Mougin C, Madoz L, et al. Viral co-infections in human papillomavirus-associated anogenital lesions according to the serostatus for the human immunodeficiency virus. Int J Cancer 1992; 52: 731–737.

    Google Scholar 

  26. Flewett TH, Parker RG, Philip WM. Acute hepatitis due to Herpes simplex virus in an adult. J Clin Pathol 1969; 22: 60–66.

    Google Scholar 

  27. Francis TI, Osuntokun BO, Kemp GE. Fulminant hepatitis due to herpes hominis in an adult human. Am J Gastroenterol 1972; 57: 329–332.

    Google Scholar 

  28. Vousden KH. p53. Death star [In Process Citation]. Cell 2000; 103: 691–694.

    Google Scholar 

  29. Porter AG. Protein translocation in apoptosis. Trends Cell Biol 1999; 9: 394–401.

    Google Scholar 

  30. Enari M, Sakahira H, Yokoyama H, Okawa K, Iwamatsu A, Nagata S. A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD. Nature 1998; 391: 43–50.

    Google Scholar 

  31. Sakahira H, Enari M, Nagata S. Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis. Nature 1998; 391: 96–99.

    Google Scholar 

  32. Irie H, Koyama H, Kubo H, et al. Herpes simplex virus hepatitis in macrophage-depleted mice: The role of massive, apoptotic cell death in pathogenesis. J Gen Virol 1998; 79: 1225–1231.

    Google Scholar 

  33. Watanabe D, Honda T, Nishio K, Tomita Y, Sugiura Y, Nishiyama Y. Corneal infection of herpes simplex virus type 2–induced neuronal apoptosis in the brain stem of mice with expression of tumor suppressor gene (p53) and transcription factors. Acta Neuropathol (Berl) 2000; 100: 647–653.

    Google Scholar 

  34. Ando K, Moriyama T, Guidotti LG, et al. Mechanisms of class I restricted immunopathology. A transgenic mouse model of fulminant hepatitis. J Exp Med 1993; 178: 1541–1554.

    Google Scholar 

  35. Ogasawara J, Watanabe-Fukunaga R, Adachi M, et al. Lethal effect of the anti-Fas antibody in mice. Nature 1993; 364: 806–809.

    Google Scholar 

  36. Kanzler S, Galle PR. Apoptosis and the liver. Semin Cancer Biol 2000; 10: 173–184.

    Google Scholar 

  37. Natori S, Rust C, Stadheim LM, Srinivasan A, Burgart LJ, Gores GJ. Hepatocyte apoptosis is a pathologic feature of human alcoholic hepatitis. J Hepatol 2001; 34: 248–253.

    Google Scholar 

  38. Ziol M, Tepper M, Lohez M, et al. Clinical and biological relevance of hepatocyte apoptosis in alcoholic hepatitis. J Hepatol 2001; 34: 254–260.

    Google Scholar 

  39. Papakyriakou P, Tzardi M, Valatas V, et al. Apoptosis and apoptosis related proteins in chronic viral liver disease. Apoptosis 2002; 7: 133–141.

    Google Scholar 

  40. Hayashi N, Mita E. Fas system and apoptosis in viral hepatitis. J Gastroenterol Hepatol 1997; 12: S223–226.

    Google Scholar 

  41. Maini MK, Boni C, Lee CK, et al. The role of virus-specific CD8(+) cells in liver damage and viral control during persistent hepatitis B virus infection. J Exp Med 2000; 191: 1269–1280.

    Google Scholar 

  42. Bertoletti A, Maini MK. Protection or damage: A dual role for the virus-specific cytotoxic T lymphocyte response in hepatitis B and C infection? [In Process Citation]. Curr Opin Immunol 2000; 12: 403–408.

    Google Scholar 

  43. Aubert M, O'Toole J, Blaho JA. Induction and prevention of apoptosis in human HEp-2 cells by herpes simplex virus type 1. J Virol 1999; 73: 10359–10370.

    Google Scholar 

  44. Perng GC, Jones C, Ciacci-Zanella J, et al. Virus-induced neuronal apoptosis blocked by the herpes simplex virus latency-associated transcript. Science 2000; 287: 1500–1503.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Laboratoire de Biologie Cellulaire et Moléculaire, Centre Hospitalier Universitaire Jean Minjoz, and Institut d'Etude et de Transfert de Gènes, Boulevard A. Fleming, 25030, Besançon Cedex, France

    J.-L. Prétet, L. Pelletier, B. Bernard, S. Coumes-Marquet & C. Mougin

  2. Laboratoire d'Anatomie-Pathologique, CHU Jean Minjoz, Boulevard Fleming Besançon, France

    B. Kantelip

Authors
  1. J.-L. Prétet
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. L. Pelletier
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. B. Bernard
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. S. Coumes-Marquet
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. B. Kantelip
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. C. Mougin
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to J.-L. Prétet.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Prétet, JL., Pelletier, L., Bernard, B. et al. Apoptosis participates to liver damage in HSV-induced fulminant hepatitis. Apoptosis 8, 655–663 (2003). https://doi.org/10.1023/A:1026156130656

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1026156130656

Search

Navigation